Lv4
684 积分 2025-11-10 加入
Targeted protein degradation: from mechanisms to clinic
12小时前
待确认
Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer's disease and related tauopathies
5天前
已完结
Heterobifunctional Molecules Induce Dephosphorylation of Kinases-A Proof of Concept Study
5天前
已完结
Targeted protein degradation: from mechanisms to clinic
17天前
已完结
Small‐Molecule PROTACS: New Approaches to Protein Degradation
17天前
已完结
PROTAC induces HIV-1 Nef degradation
18天前
已完结
Tau in physiology and pathology
21天前
已完结
Biochemistry and pharmacology of catechol-O-methyltransferase inhibitors
22天前
已完结
KT-621, an Oral, Once Daily, Targeted STAT6 Degrader: First-in-Human Phase 1a Safety, Pharmacokinetics, Pharmacodynamics and Th2 Biomarker Effects
22天前
已完结
Late Breaking Abstract - Safety, pharmacokinetics and pharmacodynamics of KT-621, an oral STAT6 degrader, in healthy adults
23天前
已关闭
皖公网安备34019202002308
